REspiratory diSEAse cohoRt Studies of CHinese Medicine for Interstitial Lung Disease (RESEARCH-ILD)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study is a traditional Chinese medicine cohort for interstitial lung disease(ILD) in China, including at least 5000 patients with ILD and followed up for at least 5 years. The aim is to focus on the demographic characteristics, clinical features, disease occurrence and development characteristics, TCM syndrome evolution patterns, and clinical efficacy of TCM treatment for ILD in the real world.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Patients who meet the diagnosis of ILD;

• Age≥18 years old;

• Ability to provide independent informed consent.

Locations
Other Locations
China
The First Affiliated Hospital of Henan University of Chinese Medicine
RECRUITING
Zhengzhou
Contact Information
Primary
Xue-qing Yu, Ph.D
yxqshi@163.com
+8613525518843
Time Frame
Start Date: 2024-04-15
Estimated Completion Date: 2030-12-30
Participants
Target number of participants: 5000
Treatments
Traditional Chinese Medicine cohort
ILD subjects who have continuously used traditional Chinese medicine for standardized treatment for 3 months or more within 1 year, or have accumulated treatment time for 6 months or more.
Non Traditional Chinese Medicine cohort
Other ILD patients who do not meet the traditional Chinese medicine cohort.
Sponsors
Leads: Henan University of Traditional Chinese Medicine

This content was sourced from clinicaltrials.gov